GSE152699 GSE152723 vemurafenib 0 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE152699_GSE152723_vemurafenib_0_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE152699_GSE152723_vemurafenib_0_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE152699_GSE152723_vemurafenib_0_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE152699_GSE152723_vemurafenib_0_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 16

Gene

multidrug resistance-related protein

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

uncharacterized LOC339260

Gene

MIR924 host gene

Gene

RNASEH1 divergent transcript

Gene

LIF antisense RNA 2

Gene

uncharacterized LOC101929494

Gene

long intergenic non-protein coding RNA 1446

Gene

ubiquitin B pseudogene 4

  • Gene

    small nucleolar RNA host gene 16


  • Gene

    multidrug resistance-related protein


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene


  • Gene

    uncharacterized LOC339260



  • Gene

    RNASEH1 divergent transcript


  • Gene

    LIF antisense RNA 2


  • Gene

    uncharacterized LOC101929494


  • Gene

    long intergenic non-protein coding RNA 1446


  • Gene

    ubiquitin B pseudogene 4

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.